DISCOVERY OF 3CL PROTEASE INHIBITOR by Dr Michael Levitt

“ For me, to be able to describe a drug that would help alleviate the effects of COVID is actually a real pleasure and treat. It's remarkable that Insilico, without the resources of a major big pharma company, has abled to actually get a drug candidate for COVID in a very short period of time. They really seem to have a scheme, a method which is working not just once, but many times to basically speed up the development of drugs.” said Dr.Michael Levitt, 2013 Nobel Laureate in Chemistry.